Vaccinex, Inc. Payments to Acquire Marketable Securities
Vaccinex, Inc. (VCNX) reported Payments to Acquire Marketable Securities of $20.76 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2020-03-09
- Vaccinex, Inc. payments to acquire marketable securities for the quarter ending 2018-12-31 was $4.66M.
- Vaccinex, Inc. payments to acquire marketable securities for fiscal 2018 was $20.76M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|
| 2018-12-31 | $4.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $20.76M 10-K · filed 2020-03-09 | |
| 2018-09-30 | $16.09M 10-Q · filed 2019-11-12 |